Background: The relationship between optimization according to left ventricular (LV) dp/ dt, changes in LV performance, and prognosis of heart failure patients who undergo cardiac resynchronization therapy (CRT) remains unclear.
Introduction
Cardiac resynchronization therapy (CRT) has been demonstrated to be beneficial for medically refractory heart failure patients with cardiac dyssynchrony. [1] [2] [3] [4] [5] However, approximately 30% of patients have been reported as non-responders to CRT.
6-9)
The optimization of both atrioventricular (AV) delay and interventricular (VV) delay is needed to improve left ventricular (LV) performance; several invasive as well as noninvasive methods for optimization have been reported to date. [10] [11] [12] [13] [14] [15] [16] [17] [18] Optimization by measurement of LV dp/dt is invasive, but can be achieved during the CRT procedure. Some studies of optimization by LV dp/dt [16] [17] [18] have been reported; however, the relationship between optimization by LV dp/dt measurement, changes in LV performance, and middle-tolong-term prognosis remains unclear.
The aim of this study was to evaluate the relationship between optimization according to the measurement of LV dp/dt, changes in LV performance, and the middle-to-long-term prognosis of patients with heart failure who undergo CRT.
Patients and Methods

Study population
We examined 27 consecutive patients who underwent CRT implantation (18 males, 9 females; age 67:3 AE 8:3 years). All patients had medically refractory heart failure with cardiac dyssynchrony, and all had appropriate indications for CRT in accordance with the guidelines of The Japanese Circulation Society.
Catheterization and stimulation protocol
Hemodynamic measurements were taken using a 4 Fr pigtail catheter during CRT implantation. The catheter was advanced into the LV via the right femoral artery, and LV dp/dt and systolic blood pressure (SBP) were calculated in real time using a digital filter. After placement of the pigtail catheter, the heart was stimulated. The protocol included single RV, LV, and biventricular (BiV) stimulation with either simultaneous (BiV0) or sequential pacing (LV pre-excitation 20, 40, 60, and 80 ms, RV preexcitation 20 and 40 ms). The optimal VV delay was determined by the maximum LV dp/dt. We compared the dp/dt and SBP values at baseline (de novo cases: sinus rhythm; upgrade cases: RV pacing) with those at optimal VV delay.
Echocardiographic, electrocardiographic, and Xray assessment and follow-up protocol Echocardiographic examination, electrocardiography and chest X-ray were performed before and 1 week after the CRT procedure. The LV ejection fraction (LVEF) was assessed by Simpson's equation using apical four-chamber and two-chamber views, 19) and LV end-diastolic diameter (LVEDD) and LV end-systolic diameter (LVESD) was evaluated by the long-axis view. We assessed the QRS duration, atrial fibrillation, and left bundle branch block in electrocardiography. The cardiothoracic ratio was calculated as a percentage of the maximal horizontal length of a cardiac shadow against that of bilateral lung fields on chest X-ray. The primary endpoint was defined as all-cause mortality and cardiac hospitalization. The determination that a primary endpoint had occurred was made after review of the patient's medical records by cardiologists. No patient was lost to follow-up. We defined the event group as those who suffered an event categorized as a primary endpoint, and the control group included subjects who had not suffered such an event.
Statistical analysis
All data are expressed as the mean AE SD or a percentage. An unpaired t-test and the 2 test were used for comparison of the mean values and parameters between the event and control groups. A paired t-test was used to analyze changes in LVEF and LVEDD. Cumulative incidences of primary endpoints were plotted as Kaplan-Meier curves, and the differences were assessed using the log-rank test. In the multiple logistic regression model for endpoints, we adjusted for age and gender. All statistical analyses were performed using the computer software package SPSS, version 15.0J (SPSS Inc., Chicago, IL). A probability value of <0:05 was considered as statistically significant.
Results
The baseline characteristics are shown in Table 1 . The underlying cardiac diseases were dilated cardiomyopathy (11 cases), ischemic heart disease (5 cases), sarcoidosis (5 cases), hypertrophic cardiomyopathy (3 cases), hypertensive heart disease (2 cases), and valvular disease (1 case).
The LV dp/dt was 896 AE 246 mmHg/s and the SBP was 102 AE 21 mmHg before CRT, and the LV dP/dt was 1;112 AE 312 mmHg/s and the SBP was 107 AE 23 mmHg according to optimal VV delay. We optimized CRT as follows: LV pre-excitation pacing was set in 19 patients, BiV pacing (LV and RV VV interval = 0 ms) in 6 patients, and RV pre-excitation pacing in 2 patients. The total subject analysis showed increased LVEF (26:7 AE 10:8 ! 35:6 AE 12:1%; p < 0:001) and decreased LVEDD (67:2 AE 10:2 ! 63:5 AE 9:2 mm; p ¼ 0:042) after CRT ( Figure 1 ). An increase in LV dp/dt during CRT was significantly and positively associated with an increase in LVEF (r ¼ 0:47, p ¼ 0:018), but was not associated with a decrease in LVEDD (r ¼ 0:05, p ¼ 0:81) ( Figure 2 ). An increase in SBP during CRT was not associated with an increase in LVEF (r ¼ 0:36, p ¼ 0:16) or with a decrease in LVEDD (r ¼ À0:09, p ¼ 0:73). An increase in LV dp/dt was not associated with a paced QRS duration (r ¼ À0:23, p ¼ 0:26).
The mean follow-up period was 14 AE 13 months, and six endpoints were observed. Five patients were admitted to the hospital due to heart failure, and one patient died due to heart failure. Comparison of event and control groups is shown in Table 2 . In the control group, no subjects suffered an endpoint, and this group showed a higher reduction in 
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Figure 2
(A) Association between an increase in left ventricular (LV) dp/dt (Ádp/dt) and an increase in left ventricular ejection fraction (LVEF) (ÁEF change%). (B) Association between an increase in LV dp/dt (Ádp/dt) and a decrease in left ventricular end-diastolic diameter (LVEDD) (ÁEDD). An increase of dp/dt was significantly associated with an increase in LVEF, but not with a decrease in LVEDD.
LVEDD (5:7 AE 8:4 vs. À2:5 AE 4:6 mm; p ¼ 0:034) than those in the event group; however, the comparative increases in dp/dt (26 AE 24 vs. 18 AE 12%, p ¼ 0:44), maximum dp/dt (1;173 AE 326 vs. 1;082 AE 289 mmHg/s, p ¼ 0:32), and changes in LVEF (49 AE 50% vs. 25 AE 39%; p ¼ 0:31) did not reach statistical significance ( Table 2) . Cox regression analysis revealed that a reduction in LVEDD was a significant predictor of endpoint (odds ratio: 0.80, 95% confidence interval 0.63-0.996, We divided all subjects into two groups according to the median LVEDD reduction (3 mm), and the group showing greater reduction experienced fewer endpoints (Log rank = 4.64, p ¼ 0:031; Figure 3 , Panel A). We also divided the subjects into two groups according to the median increase in LV dp/dt (20%), the difference between endpoints in each group was not significant (Log rank = 0.95, p ¼ 0:33; Figure 3 , Panel B). cumulative event-free survival stratified by the median value of increase in left ventricular (LV) dp/dt. Patients with an LVEDD reduction above the median value showed a higher rate of eventfree survival. On the other hand, patients with an increase in left ventricular (LV) dp/dt that was above or below the median showed similar rates of event-free survival.
Discussion
The two main findings of this study were that increases in LV dp/dt were associated with increases in LVEF, and that decreases in LVEDD were predictive of event-free survival.
Inter-ventricular delay caused a shortening of LV diastolic filling time, an increase in mitral regurgitation, and a decrease in LV dp/dt; in general, a worsening of hemodynamic status was seen among heart failure patients.
20) It has been shown that an improvement in dyssynchrony causes increased LV dp/dt.
16-18) Doppler-derived LV dp/dt is known to be related to the degree of LV dyssynchrony, and the dp/dt calculated during the early phases of systole during isovolumic contraction played a role as a mechanism of the relationship between LV dp/dt and the degree of LV dyssynchrony. 21) In this study, we demonstrated that LV dp/dt and SBP had increased after CRT, and that increases in dp/dt were associated with increases in LVEF. Therefore, the optimization of VV delay by measurement of the LV dp/dt results enhanced increases in the LVEF. Thus, this approach might be useful for improving the prognosis of heart failure patients who undergo CRT. The optimization of VV delay is particularly important in nonresponders who undergo an optimization of AV delay to reduce cardiac preload;
16) it appears likely that the optimization of VV delay by LV dp/dt may have contributed, in these cases, to an increase in the rate of responders to CRT.
The LVEF, LVESD, and LVEDD are used as parameters of improvement in cardiac function. A decrease in LVEDD was viewed as a predictor of event-free survival in this study. It has been shown that decreases in LV diameter are associated with cardiovascular events and mortality. 22) When only the optimization of VV delay was addressed, LV reverse remodeling by CRT was found to be insufficient.
23) Therefore, the optimization of AV delay is also necessary to achieve sufficient LV reverse remodeling. Optimal pharmacotherapy is also important for improving the prognosis of heart failure patients who have undergone CRT. 24) Although heart failure management should include the utilization of evidence-based treatment, optimal pharmacological treatment is not administered in most cases. 25) Auricchio et al. demonstrated that LV end-diastolic pressure did not differ among responders and nonresponders in the acute phase of disease.
16) Within a relatively short observational period, optimization by VV delay did not yield a sufficient reduction in LV diameter, even among responders. In this study, a reduction in LVEDD 1 week after CRT implantation was the best predictor of event-free survival. The cardiothoracic ratio might be a useful parameter in the same capacity.
LV dp/dt was associated with increases in LVEF, but an increase of LV dp/dt was not associated with event-free survival. Two explanations for this discrepancy might be considered. First, reverse remodeling in the chronic phase might not be associated with an increase of LV dp/dt, and the increase of LVEF, which was assessed by echocardiographic examination 1 week after the CRT procedure, may not have been sufficient to predict long-term prognosis. And second, the absolute value of LV dp/dt, but not an increase of dp/dt, might have been associated with prognosis. In this study, although maximum LV dp/dt did not differ significantly in the case and control group, further studies including larger numbers of subjects will be needed to clarify the association between the absolute value of LV dp/dt after CRT implantation and long-term prognosis.
This study included some limitations. First, the sample size was relatively small and there was no long-term follow-up. Second, we did not obtain enough echocardiographic examination data over the follow-up period. These factors might have affected the discrepancy between the increase of LVEF and clinical outcomes regarding CRT optimization using dp/dt. We could not obtain and assess data on the 6-min walking distance, which was used as an index of responders to CRT. Future studies including a larger sample and index of quality of life will be needed to clarify the relationship between increased LV dp/dt and long-term prognosis.
Conclusions
Changes in LV dp/dt might be useful for optimizing CRT. Amelioration of clinical symptoms, reflected by a reduction in LVEDD, is needed to achieve an improvement in the long-term prognosis of CRT patients. utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 2005; 26: 2706-2713
